References
- DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
- GOLDGlobal Initiative for Chronic Obstructive Lung Disease [updated January 18, 2015]. Available from: http://www.goldcopd.org/Accessed January 15, 2015
- ZhongNWangCYaoWPrevalence of chronic obstructive pulmonary disease in China: a large, population-based surveyAm J Respir Crit Care Med2007176875376017575095
- Chronic Obstructive Pulmonary Disease Study Group, Thoracic Society, Chinese Medical Association (CMACOPDS)Guideline for diagnosis and treatment of COPDZhonghua Jie He He Hu Xi Za Zhi2007301817 Chinese
- VestboJAndersonJACalverleyPMAAdherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
- IngebrigtsenTSMarottJLNordestgaardBGLow use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general populationJ Gen Intern Med2015301515925245885
- CarterBLRogersMDalyJZhengSJamesPAThe potency of team-based care interventions for hypertension: a meta-analysisArch Intern Med2009169191748175519858431
- CollinsCLimoneBLScholleJMColemanCIEffect of pharmacist intervention on glycemic control in diabetesDiabetes Res Clin Pract201192214515220961643
- HessLMRaebelMAConnerDAMaloneDCMeasurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresAnn Pharmacother2006407–81280128816868217
- KhdourMRKidneyJCSmythBMMcElnayJCClinical pharmacy-led disease and medicine management programme for patients with COPDBr J Clin Pharmacol200968458859819843062
- RodrigoGJPlazaVEfficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: a systematic reviewChest2014146230931724556877
- NonatoNLDíazONascimentoOADreyseJJardimJRLisboaCBehavior of quality of life (SGRQ) in COPD patients according to BODE scoresArch Bronconeumol201551731532125622995
- WellingJBHartmanJETen HackenNHKloosterKSlebosDJThe minimal important difference for the St George’s Respiratory Questionnaire in patients with severe COPDEur Respir J20154661598160426493797
- BrownPBlumlBMKritzlerRWhite paper on expanding the role of pharmacists in chronic obstructive pulmonary diseaseJ Am Pharm Assoc2011512203211
- TommeleinETollenaereKMehuysEBousseryKPharmaceutical care for patients with COPD in Belgium and views on protocol implementationInt J Clin Pharm201436469770124858598
- SpruitMAAugustinIMVanfleterenLEDifferential response to pulmonary rehabilitation in COPD: multidimensional profilingEur Respir J20154661625163526453626
- BurtinCTer RietGPuhanMAHandgrip weakness and mortality risk in COPD: a multicentre analysisThorax2016711868726514408
- JordanREMajothiSHeneghanNRSupported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysisHealth Technol Assess201519361516
- McGeochGRWillsmanKJDowsonCASelf-management plans in the primary care of patients with chronic obstructive pulmonary diseaseRespirology200611561161816916335
- CrinerGJBourbeauJDiekemperRLPrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society GuidelineChest2015147489494225321320
- Garcia-AymerichJHernandezCAlonsoAEffects of an integrated care intervention on risk factors of COPD readmissionRespir Med200710171462146917339106
- HansenRAKimMMSongLTuWWuJMurrayMDComparison of methods to assess medication adherence and classify nonadherenceAnn Pharmacother200943341342219261962